title: Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals.
abstract: The immune responses to Mycobacterium leprae and other mycobacterial antigens were studied in 11 leprosy patients with concurrent human immunodeficiency virus type 1 (HIV-1) infection. Three patients manifested borderline lepromatous leprosy, and eight patients had borderline tuberculoid (BT) leprosy. Despite the low CD4+ T-cell count in the peripheral blood, no histologic or phenotypic change in the cellular infiltrate in either the lepromatous or tuberculoid lesions was observed when compared with HIV-1-negative patients. Lepromatous lesions contained heavily parasitized macrophages and few CD8+ T cells. Lesions from the patients with BT leprosy showed extensive CD4+ T-cell infiltration despite a significant reduction in CD4+ T-cell counts in the peripheral blood. No acid-fast bacilli were detected in the tuberculoid lesions. HIV-1 infection did not alter the lack of response in lepromatous leprosy to M. leprae antigens either in vitro or in vivo. In contrast, the skin test response to M. leprae antigens as well as the in vitro lymphoproliferative responses to mycobacterial antigens that are usually seen in patients with tuberculoid leprosy were abrogated in the BT HIV-1+ patients. However, production of gamma interferon in response to the same stimuli was preserved in most of the patients. Analysis of cytokine gene expression showed activation of additional cytokine genes in the unstimulated peripheral blood cells of patients with both leprosy and HIV-1 infections as compared with cells from patients with leprosy alone. These results suggest that granuloma formation in leprosy can be independent of the impaired CD4+ T-cell response of the HIV-1 infection. Furthermore, in HIV-1+ individuals with M. leprae infection, activation of cytokine genes is observed even when the circulating CD4+ T-cell count is significantly reduced.
authors.affiliation: Leprosy Department, Oswaldo Cruz Foundation, Manguinhos, Rio de Janeiro, Brazil.
authors.forename: E P
authors.initials: EP
authors.lastname: Sampaio
authors.forename: J R
authors.initials: JR
authors.lastname: Caneshi
authors.forename: J A
authors.initials: JA
authors.lastname: Nery
authors.forename: N C
authors.initials: NC
authors.lastname: Duppre
authors.forename: G M
authors.initials: GM
authors.lastname: Pereira
authors.forename: L M
authors.initials: LM
authors.lastname: Vieira
authors.forename: A L
authors.initials: AL
authors.lastname: Moreira
authors.forename: G
authors.initials: G
authors.lastname: Kaplan
authors.forename: E N
authors.initials: EN
authors.lastname: Sarno
mesh_terms: D000942:Antigens, Bacterial / Q000276:immunology; D018791:CD4 Lymphocyte Count; D016516:CD4-CD8 Ratio; D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics; D015870:Gene Expression; D015658:HIV Infections / Q000150:complications / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007916:Lepromin / Q000276:immunology; D007918:Leprosy / Q000150:complications / Q000276:immunology* / Q000473:pathology; D015440:Leprosy, Lepromatous / Q000276:immunology; D015441:Leprosy, Tuberculoid / Q000276:immunology; D007963:Leukocytes, Mononuclear / Q000276:immunology; D008213:Lymphocyte Activation; D012333:RNA, Messenger / Q000032:analysis; D012867:Skin / Q000473:pathology
chemical_list: D000942:Antigens, Bacterial; D016207:Cytokines; D012333:RNA, Messenger; D007916:Lepromin